losartan has been researched along with Brain Diseases in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
Excerpt | Relevance | Reference |
---|---|---|
"The results indicated that systemic inflammation had deleterious long-lasting consequences on brain, which were reversed by pretreatment with losartan." | 7.88 | Angiotensin receptor blocker, losartan ameliorates neuroinflammation and behavioral consequences of lipopolysaccharide injection. ( Baghcheghi, Y; Beheshti, F; Hosseini, M; Khazaei, M; Sadeghnia, HR; Salmani, H; Shafei, MN; Soukhtanloo, M, 2018) |
"The results indicated that systemic inflammation had deleterious long-lasting consequences on brain, which were reversed by pretreatment with losartan." | 3.88 | Angiotensin receptor blocker, losartan ameliorates neuroinflammation and behavioral consequences of lipopolysaccharide injection. ( Baghcheghi, Y; Beheshti, F; Hosseini, M; Khazaei, M; Sadeghnia, HR; Salmani, H; Shafei, MN; Soukhtanloo, M, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Salmani, H | 1 |
Hosseini, M | 1 |
Beheshti, F | 1 |
Baghcheghi, Y | 1 |
Sadeghnia, HR | 1 |
Soukhtanloo, M | 1 |
Shafei, MN | 1 |
Khazaei, M | 1 |
1 other study available for losartan and Brain Diseases
Article | Year |
---|---|
Angiotensin receptor blocker, losartan ameliorates neuroinflammation and behavioral consequences of lipopolysaccharide injection.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Behavior, Animal; Brain Diseases; Inflammation; Li | 2018 |